Opto Circuits (India) Ltd. 1Opto Circuits (India) Ltd. 2 Disclaimer This presentation contains...

Opto Circuits (India) Ltd. 1


Disclaimer

This presentation contains statements that contain “forward looking statements” including, butwithout limitation, statements relating to the implementation of strategic initiatives, and otherstatements relating to Opto Circuits (India) Limited and its subsidiary companies (“Opto Circuits”)future business developments and economic performance.

While these forward looking statements indicate our assessment and future expectationsconcerning the development of our business, a number of risks, uncertainties and other unknownfactors could cause actual developments and results to differ materially from our expectations.

These factors include, but are not limited to, general market, macro-economic, governmental andregulatory trends, movements in currency exchange and interest rates, competitive pressures,technological developments, changes in the financial conditions of third parties dealing with us,legislative developments, and other key factors that could affect our business and financialperformance.

Opto Circuits undertakes no obligation to periodically revise any forward looking statements toreflect future / likely events or circumstances.


Section 1: Company Overview


A fast growing multinational medical device company

Ma

rke

t L

ea

de

rsh

ipB

est

-in

-Cla

ss O

pe

rati

on

s

World class manufacturing facilities across North America, Europe and Asia

Investments in R&D to maintain a healthy pipeline of innovations and product developments

4 global R&D centres with highly skilled and integrated teams

Global sales offices and relationships with marquee distributors

Leader in vital signs monitoring, emergency cardiac care, vascular treatments and sensing

technologies

USFDA listed and CE marked products which are sold in over 150 countries

Partnerships with leading OEMs and medical institutions across the value chain

Well-known brands include Cardiac Science, Criticare Systems, Eurocor and Mediaid

Investment HighlightsCompany Overview


Diversified product portfolio with market leadership position

Segment Breakup

Medical Equipment

o Monitoring: Vital Signs, Anaesthesia & Thermometers

o Treatment: Defibrillation Products

o Diagnostics: Vascular Diagnostic Systems

o Consumables, Accessories and Services

FY2015 Revenue: 90%

Company Overview

Interventional Devices

o Vascular: Cardiac Stents, Balloons and accessories

o Orthopedics: Hip Implants, Suction Devices, Surgical Tools Physiotherapy Products

o Urology, Gastroenterology and Gynaecology: Catheters, Stents, Guidewires, Dilator Sets, Needles, Baskets, Injectors

FY2015 Revenue: 9.6%


Group Company BRANDSCompany Overview


Global Product Brands & TrademarksCompany Overview


Quality and cost optimization

Manufacturing Facilities

o Move manufacturing lines from high cost locations to cost efficient locations in Malaysia and India

o Keep selective product lines in the US and Europe

o New Asian manufacturing bases to help cater to the fast growing markets in MENA and SEA

o Closer to the growing customer base will enable faster logistics and an efficient supply chain

Company Overview

India

Malaysia

USA

Europe


OEM PortfolioCompany Overview

Reusable and Disposable Sensors

Water Traps

Digital Thermometers

Vital Signs Monitor

Fetal Pulse OximeterAgent Gas Bench

Defib Monitor

Responder AED Pro

MRI friendly Vital Signs Monitor

Powerheart G3 AED

Aanesthesia Module

NIBP Module

AED Pads

NIBP Cuffs


OEM PartnershipsCompany Overview

OEM

• Specialist in SPO2 and

respiratory &

anesthetic

technologies

• Customized full

service solutions

• Strengthens

relationships to

generate additional

business

White Label

• Consumables and

accessories for group

purchase

organizations/

distributors

• Aids institutional

bundling

Branded Consumables

• Proprietary sensing

technology for SPO2

• Low cost

manufacturing base for

group companies


Attractive dynamics of the global med-tech industry

Industry Overview

Market Size Growth Trends

Vit

al

Sig

ns

Mo

nit

ori

ng

Current: $7 bn

2016: +$8 bn

Technological advances

Ageing population

Lack of infrastructure in emerging markets

An

est

he

sia

a

nd

Ga

s M

on

ito

rin

g

Current: $4.8 bn

2016: +$7.3 bn

Growing safety awareness

Technology enhancements

Government regulation

Pe

rip

he

ral

Va

scu

lar

Dia

gn

ost

ics

Current: $180 mn

2016: $300 mn

Peripheral Arterial Disease (PAD) awareness

New detection technologies

Company Overview


Attractive dynamics of the global med-tech industry

Industry Overview

Market Size Growth Trends

Ex

tern

al

De

fib

rill

ati

on

Current: $600 mn

2016: $842 mn

Awareness of the incidence of sudden cardiac arrest

Increasing government legislation promoting or requiring external defibrillator installation

Opportunities in the emerging markets

Co

ron

ary

S

ten

t

Current: $5.4 bn

2016: $6.5 bn

Dramatic rise in cardiovascular disease

Acceptance of minimally invasive procedures

Expansion of Cath Lab infrastructure

Dru

g-E

luti

ng

B

all

oo

ns

Current: $0.8 bn

2016: $1.3 bn

Minimally invasive alternative to bypass surgery

Reduction in risk and cost vs. DES

Increasing rate of ISR (In-stent Restenosis)

Company Overview


Section 2: Financials


FY16 FinancialsCompany Overview

P&L Synopsis

Q1 y-o-y

FY2016 FY2015 Growth %

Sales 2,502 3,133 -20%

Gross Profit 1,296 1,426 -9%

Margin % 52% 46%

EBITDA 664 692 -4%

Margin % 27% 22%

Profit / (Loss) 86 94 -9%

Margin % 3% 3%

EPS 0.35 0.39

Rs. Mn.


Strong and experienced management

Corporate Governance

Key Executive Designation

Vinod Ramnani Chairman and Managing Director

Thomas Dietiker

Director, M&A and OEM Business

Jayesh Patel Director, Engineering

Company Overview

Independent board of directors

Board Member Background

Dr. Anvay Mulay

HOD, Adult Cardiac Surgery at theDhirubhai Ambani Hospital

Dr. SulemanMerchant

HOD, Radiology at Lokmanya TilakMemorial Medical College & Hospital

RajkumarRaisinghani

Industrialist

Suchitra MisraDoctor of Philosophy and founder of‘The Healing Garden

Shareholding pattern

Note: As of June 30, 2015

BSE Code: 532391

NSE Code: OPTOCIRCUI

Shares O/S in Crs: 24.2

28.28%

17.72%54%

Promoters Institutions Others


SummaryCompany Overview

o India-headquartered medical device enterprise with a global focus on high growth product lines in developed and emerging markets

o Diversified product portfolio with an emphasis on devices with consumable components and a long-term increasing demand trend

o Highly efficient global manufacturing and distribution infrastructure supported by focused top- tier management teams for both medical equipment and interventional products

o Leadership position in key product lines secured by broad IP portfolio combined with continuing investment in product development and innovation

o Focus on driving organic growth and maximizing profitability


#83, Electronics City

Bengaluru - 560 100

Karnataka, India

Phone : +91 80 28521040/ 41/ 42 | Fax : +91 80 2852 1094

Web: www.optocircuits.com

Email: [email protected]

Opto Circuits (India) Ltd.

http://www.optocircuits.com/

mailto:[email protected]

Opto Circuits (India) Ltd. 1Opto Circuits (India) Ltd. 2 Disclaimer This presentation contains...

Documents

Transcript of Opto Circuits (India) Ltd. 1Opto Circuits (India) Ltd. 2 Disclaimer This presentation contains...